Airxpanders

Executive Series - AirXpanders (AXP) CEO & President, Scott Dodson

CommSec

Tom Piotrowski speaks with AirXpanders (AXP) CEO & President, Scott Dodson about the company’s performance since listing on the ASX 18 months ago & its recently received FDA approval for its AeroForm product To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series.html Show More

AirXpanders (ASX: AXP) - Big step forward for patients, potentially big money for investors

Stuart Roberts

Some of the greatest healthcare plays I know involve a new product that is not only safe and effective but replace a current treatment modality best described as 'brutal'. AirXpanders (ASX: AXP), a >A$270m company which went public on ASX in 2015, is a great example. This company's AeroForm technology... Show More